When community members finally meet someone else with their diagnosis
I recently attended the CHES Foundation's One Drop conference in Florida
Written by |
On Nov. 13, I hopped in my car and drove to Tampa, Florida, to attend One Drop, the CHES Foundation‘s gathering for people living with ultra-rare factor and platelet deficiencies.
Most of those who were headed to One Drop this year flew in, landing in Tampa in the morning or early afternoon. Hours later, the Federal Aviation Administration halted flights nationwide, resulting in the longest nationwide ground stop in 25 years. By Saturday, more than 6,600 flights had been canceled. Most One Drop participants made it with hours or minutes to spare, but not everyone was that lucky.
Why getting there matters
I’ve written about One Drop before. What I keep coming back to is how few places like it exist.
Ultra-rare communities depend on a handful of gatherings, a handful of organizers, and a limited pool of funding. When one weekend gets knocked sideways by something no one controls, there isn’t another conference next month to make up for it.
For many of these families, there is no local support group. No chapter meeting where someone else has the same deficiency. Some have never met another person with their diagnosis. One Drop is often the only room where that happens.
Families fly in Friday and fly out Sunday, and airfare, hotel, and meals are covered by CHES. This year, with a smaller budget, attendance was limited to one or two people per family.
So when the flights stopped, the question quickly shifted. Since most people were already there, the worry became whether they would get home. For families managing an ultra-rare bleeding disorder, a stranded night isn’t just a hassle. It means stretching treatment, finding care in an unfamiliar city, and doing it far from the people who know you.
Most of the room made it. One speaker didn’t — their flight got caught in the ground stop, so Tammuella Singleton, MD, a legend in our community, who saw her flight out get canceled, stayed and delivered the other speaker’s talk. The same shutdown that kept one physician away kept another one with us. That’s the kind of quiet rescue this community is good at.
Sunday brought its share of delays, but everyone did make it home safely.
Rare doesn’t have to mean alone
What stayed with me most wasn’t on the agenda. It was watching people meet someone else with their diagnosis. Many had never had that chance.
When your disorder affects a handful of people in the country, you can spend years explaining it to doctors, teachers, and family without ever sitting across from someone who just knows. At One Drop, that finally happened for a lot of people.
I’m grateful to top-level sponsors Novo Nordisk and Kedrion Biopharma, and to the others who helped make this year’s One Drop possible, especially in a year with less to go around. Their support put families in the same room who might never have met otherwise.
One Drop deserves our community’s support. Many of us now have more treatment options than ever. People with ultra-rare bleeding disorders are lucky if they have even one. If you are looking for a Giving Tuesday campaign to support, might I suggest the CHES Foundation?
The planes stopped. The room still filled. And for one weekend, people who are usually the only one in the room with their diagnosis weren’t. That’s worth protecting.
Note: Hemophilia News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or another qualified healthcare provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The opinions expressed in this column are not those of Hemophilia News Today or its parent company, Bionews, and are intended to spark discussion about issues pertaining to hemophilia.

Leave a comment
Fill in the required fields to post. Your email address will not be published.